Abstract
Aggregation or reversible self-association of protein therapeutics can arise through a number of different mechanisms. Five common aggregation mechanisms are described and their relations to manufacturing processes to suppress and remove aggregates are discussed.
Keywords: Aggregation, self-association, mechanism, nucleation
Current Pharmaceutical Biotechnology
Title: Mechanisms of Protein Aggregation
Volume: 10 Issue: 4
Author(s): John S. Philo and Tsutomu Arakawa
Affiliation:
Keywords: Aggregation, self-association, mechanism, nucleation
Abstract: Aggregation or reversible self-association of protein therapeutics can arise through a number of different mechanisms. Five common aggregation mechanisms are described and their relations to manufacturing processes to suppress and remove aggregates are discussed.
Export Options
About this article
Cite this article as:
Philo S. John and Arakawa Tsutomu, Mechanisms of Protein Aggregation, Current Pharmaceutical Biotechnology 2009; 10 (4) . https://dx.doi.org/10.2174/138920109788488932
DOI https://dx.doi.org/10.2174/138920109788488932 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effect of Simvastatin use on Autonomic Function in Patients with End Stage Renal Disease
Cardiovascular & Hematological Disorders-Drug Targets Current Therapeutic Strategies and Future Perspectives for the Prevention of Arterial Thromboembolism: Focus on Atrial Fibrillation
Current Pharmaceutical Design ACKNOWLEDGEMENTS TO REVIEWERS
Endocrine, Metabolic & Immune Disorders - Drug Targets Hypoxia and Inflammation in Prostate Cancer Progression. Cross-talk with Androgen and Estrogen Receptors and Cancer Stem Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Differential Expression of Resistant and Efflux Pump Genes in MDR-TB Isolates
Endocrine, Metabolic & Immune Disorders - Drug Targets Meet Our Editorial Board Member
Recent Patents on Inflammation & Allergy Drug Discovery Glucose Lowering Activity of Anvillea Radiata Coss & Durieu in Diabetic Rats
Cardiovascular & Hematological Disorders-Drug Targets Role of the Renin-Angiotensin-Aldosterone System in the Pathogenesis of Atherosclerosis
Current Pharmaceutical Design Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds
Endocrine, Metabolic & Immune Disorders - Drug Targets Anticancer Drug Discovery Targeting DNA Hypermethylation
Current Medicinal Chemistry Amyloidogenicity of p53: A Hidden Link Between Protein Misfolding and Cancer
Current Protein & Peptide Science Insights into the Molecular Mechanism of hERG1 Channel Activation and Blockade by Drugs
Current Medicinal Chemistry From Gene to Epigene-Based Therapies Targeting the Vascular Endothelium
Current Vascular Pharmacology Endothelial Activation. Sliding Door to Atherosclerosis
Current Pharmaceutical Design Self-management of Diabetes in Children and Young Adults Using Technology and Smartphone Applications
Current Diabetes Reviews Nicotine Addiction and Coronary Artery Disease: Impact of Cessation Interventions
Current Pharmaceutical Design Pegylated Fluorescent Peptides as Substrates of Proteolytic Enzymes
Protein & Peptide Letters Insulin and Lispro Insulin: What is Common and Different in their Behavior?
Current Protein & Peptide Science Cognitive Function and Quality of Life in Mild Thyroid Hormone Deficiency
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Osteoporosis Requires Bone-Specific Statins
Current Pharmaceutical Design